×

Concerned about your own or
someone else’s drug use?

Webinars

Drug & Alcohol Research and Innovation Active-Learning

DARIA

DARIA is the Drug and Alcohol Research and Innovation Active-Learning Network.

DARIA is a virtual, weekly seminar program delivered by St Vincent’s Hospital Sydney Alcohol and Drug Service (SVHS ADS) and the National Centre for Clinical Research on Emerging Drugs (NCCRED) in collaboration with Southern NSW Local Health District,  Murrumbidgee Local Health District, Far West NSW Local Health District, and Western New South Wales Local Health District.

The aim of the series is to promote innovative practice and share learnings and new ideas among clinicians and clinical researchers working in the field of methamphetamine, emerging drugs, and other areas of alcohol and drug health.

There are two types of seminars in the DARIA series: Journal Club, where research papers are reviewed and critiqued by presenters; and Presentations, where research findings are presented.

DARIA is held every Monday (except public holidays) from 2:30pm – 3:30pm

DARIA is held every Monday (except public holidays) from 2:30pm – 3:30pm

The Alcohol and drug Cognitive Enhancement (ACE) Program – 26th September 2022

Presented by Dr Jamie Berry

Clinical Neuropsychologist, Director of group private practice, Advanced Neuropsychological Treatment Services (ANTS)
Clinical Associate Professor, Faculty of Medicine, Health and Human Science at Macquarie University


Novel Opioids – Case Series on the use of Kamini – 19th September 2022

Presented by Dr Thileepan Naren

GP & Addiction Medicine Advanced Trainee, Western Health Melbourne. Co-host of Cracking Addiction podcast


Motivational Interviewing & Stages of Change – 12th September 2022

Presented by Dr David St Quintin

Clinical Psychologist, Illawarra Shoalhaven Local Health District


Open-label trial of oral lisdexamfetamine for the treatment of acute methamphetamine withdrawal (the OLAM study) – 5th September 2022

Presented by Liam Acheson

PhD Candidate, NDARC, The University of New South Wales (UNSW)

Research Officer, St Vincent’s Hospital Sydney


Injectable Hydromorphone – Feasibility of Opioid Injecting Trial (FOPiT) – 22nd August 2022

Presented by Dr Craig Rodgers B Med MPH FRACGP FAChAM

Senior Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney


Use of dexmedetomadine in alcohol withdrawal delirium – 15th August 2022

Presented by Dr Chris Tremonti FAChAM FRACP

Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney


Alcohol use in Aboriginal and Torres Strait Islander Communities – Recent research and evidence – 1st August 2022

Kate Conigrave – Addiction Medicine Specialist and Public Health Physician, Royal Prince Alfred Hospital, Co-Director Centre of Research Excellence in Indigenous Health and Alcohol

Teagan Weatherall – Kamilaroi and Anaiwan woman, PhD candidate University of Sydney, Research assistant CRE in Indigenous Health and Alcohol


Methamphetamine use during pregnancy – 25th July 2022

Presented by Dr Angela O’Connor

Nurse and Midwife, Clinical Lead, North Metro Health Service


Motivational Interviewing and Trauma in the AOD space – 18th July 2022

Presented by Dr David St Quintin

Clinical Psychologist, Illawarra Shoalhaven Local Health District


Telehealth Ambulatory Alcohol Withdrawal: Clean Slate Clinic – 4th July 2022

Presented by Dr Chris Davis

Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney, Clean Slate Clinic


ChemSex and harm reduction for gay and bisexual men in Australia – 27th June 2022

Presented by A/Prof Adam Bourne

Australian Research Centre in Sex, Health & Society, LaTrobe University


Capacity and Substance Use Disorder – Alcohol – 20th June 2022

Presented by Dr Chris Ryan

Clinical Associate Professor, University of Sydney

Director of Consultation-Liaison Psychiatry, Westmead Hospital Clinical School


GHB Experiences and cultures of practices amongst LGBTQ people – 6th June 2022

Presented by Mr Jack Freestone

Alcohol and Other Drugs Research and Development, ACON

PhD Candidate, NCCRED & Kirby Institute, UNSW


Nitrous oxide-induced myeloneuropathy – 30th May 2022

Presented by Dr Grace Swart

Neurologist, Brain and Mind Centre, University of Sydney


Psychedelics for the treatment of substance use disorders – 16th May 2022

Presented by Dr Jonathan Brett

Associate Professor, The University of New South Wales (UNSW)

Senior staff specialist, Clinical Pharmacology, Toxicology and Addiction Medicine, St Vincent’s Hospital Sydney


The role of electronic cigarettes to quit smoking – 9th May 2022

Presented by Prof Hayden McRobbie

Professor, National Drug and Alcohol Research Centre, UNSW, Sydney Australia

Consultant in Lifestyle Medicine, Lakes District Health Board, Rotorua, New Zealand


Methadone Buprenorphone Transfers – 11th April 2022

Presented by Dr Chris Tremonti FAChAM FRACP

Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney


Pharmacotherapy for Methamphetamine Use Disorder – 4th April 2022

Presented by Dr Krista Siefried

Clinical Research Lead and Deputy Director, National Centre for Clinical Research on Emerging Drugs (NCCRED)

Senior Lecturer, The University of New South Wales (UNSW)

Senior Research Fellow, Alcohol and Drug Service, St Vincent’s Hospital Sydney


Opioid Vs opioid-free analgesia after surgical discharge – 29th August 2022

Presented by Dr Eleanor McLaren MBChB BSc

Emergency Medicine Registrar, St Vincent’s Hospital Sydney


Clinical management of cannabis withdrawal – 8th August 2022

Presented Dr Georgie Mair

GP Registrar, Alcohol and Drug Service, St Vincent’s Hospital Sydney


Baclofen to prevent relapse in GHB dependent patients – 11th July 2022

Presented by Dr Ryan Cocker

Psychiatry (Addictions) Advanced Trainee, Alcohol and Drug Service, St Vincent’s Hospital Sydney

 


Pharmacotherapies for Methamphetamine Withdrawal – 23rd May 2022

Presented by Mr Liam Acheson

PhD Candidate, NDARC, The University of New South Wales (UNSW)

Research Officer, St Vincent’s Hospital Sydney


Bupropion and naltrexone for methamphetamine use disorder – 2nd May 2022

Presented by Dr Jeku Jacob

Paper discussed: Trivedi, M. H., Walker, R., Ling, W., Dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., Rush, A. J., Nunes, E. V., & Shoptaw, S. (2021). Bupropion and Naltrexone in Methamphetamine Use Disorder. New England Journal of Medicine384(2), 140–153. https://doi.org/10.1056/NEJMoa2020214

FORMAT

DATE

PRESENTER

TOPIC

10th October 2022 APSAD CONFERENCE
Presentation 17th October 2022 Dr Suzie Hudson Case Management and Care Planning Clinical Guidelines in the AOD sector
Journal Club 24th October 2022 Dr Roman Pillay TBC
  31st October 2022 TBC


7th November 2022 NCCRED Symposium
Free for all –  REGISTER HERE
Presentation  14th November 2022 Adele Sheridan Magro Situational Counselling for Domestic Violence Disclosure – AOD Context
Presentation 21st November 2022 Dr Jay Ramanathan & Dr Una Nic Ionmhain Cannabis hyperemesis management
28th November 2022 TBC
5th December 2022 TBC
  12th December 2022 TBC